乳癌用内分泌療法薬の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024）

• 英文タイトル：Global Endocrine Therapy Drugs for Breast Cancer Market 2019 by Company, Regions, Type and Application, Forecast to 2024

• レポートコード：B-GIR08C2080 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール • 産業分類：Pharma & Healthcare

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートは、乳癌用内分泌療法薬の世界市場について調べ、まとめました。種類別セグメントは、タモキシフェン、アナストロゾール、エキセメスタン、レトロゾール、ゴセレリン、フルベストラント等、用途別セグメントは、工業、農業、航空宇宙、防衛、その他等に区分しました。乳癌用内分泌療法薬の世界市場概観、企業動向、企業別乳癌用内分泌療法薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・乳癌用内分泌療法薬の市場概観 ・乳癌用内分泌療法薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・乳癌用内分泌療法薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・乳癌用内分泌療法薬の世界市場規模 ・乳癌用内分泌療法薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・乳癌用内分泌療法薬のアメリカ市場規模推移 ・乳癌用内分泌療法薬のカナダ市場規模推移 ・乳癌用内分泌療法薬のメキシコ市場規模推移 ・乳癌用内分泌療法薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・乳癌用内分泌療法薬のドイツ市場規模推移 ・乳癌用内分泌療法薬のイギリス市場規模推移 ・乳癌用内分泌療法薬のロシア市場規模推移 ・乳癌用内分泌療法薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・乳癌用内分泌療法薬の日本市場規模推移 ・乳癌用内分泌療法薬の中国市場規模推移 ・乳癌用内分泌療法薬の韓国市場規模推移 ・乳癌用内分泌療法薬のインド市場規模推移 ・乳癌用内分泌療法薬の東南アジア市場規模推移 ・乳癌用内分泌療法薬の南米市場分析（ブラジル、アルゼンチン等） ・乳癌用内分泌療法薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・乳癌用内分泌療法薬の種類別分析/販売量、売上、市場シェア（タモキシフェン、アナストロゾール、エキセメスタン、レトロゾール、ゴセレリン、フルベストラント） ・乳癌用内分泌療法薬の用途別分析/市場規模（工業、農業、航空宇宙、防衛、その他） ・乳癌用内分泌療法薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・乳癌用内分泌療法薬の販売チャネル・代理店・貿易業者・ディーラー分析

Scope of the Report:
The global Endocrine Therapy Drugs for Breast Cancer market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of xx% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Endocrine Therapy Drugs for Breast Cancer.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Endocrine Therapy Drugs for Breast Cancer market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Endocrine Therapy Drugs for Breast Cancer market by product type and applications/end industries.

Market Segment by Companies, this report covers
Teva
Amneal Pharms
AstraZeneca
Novartis
Intas Pharmaceuticals
Chemo
Accure Labs
Natco
Zydus Pharmaceuticals
Sanofi
Pfizer
Mylan 
Wockhardt
Cipla
Actiza Pharmaceutical
Hikma Pharmaceuticals
Shanghai Forward Technology
Bayer
Liaoning Kangtai Pharmaceutical
Fu ‘an Pharmaceutical Group
Apotex
Taro
Sun Phamaceutical
Intas Pharmaceuticals
Chemo
Accure Labs
Sun Pharmaceutical

Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Tamoxifen
Anastrozole
Exemestane
Letrozole
Goserelin
Fulvestrant

Market Segment by Applications, can be divided into
Hospital
Clinic
Drug Center
Other

レポート目次

---

Table of Contents

1 Endocrine Therapy Drugs for Breast Cancer Market Overview
1.1 Product Overview and Scope of Endocrine Therapy Drugs for Breast Cancer
1.2 Classification of Endocrine Therapy Drugs for Breast Cancer by Types
1.2.1 Global Endocrine Therapy Drugs for Breast Cancer Revenue Comparison by Types (2019-2024)
1.2.2 Global Endocrine Therapy Drugs for Breast Cancer Revenue Market Share by Types in 2018
1.2.3 Tamoxifen
1.2.4 Anastrozole
1.2.5 Exemestane
1.2.6 Letrozole
1.2.7 Goserelin
1.2.8 Fulvestrant
1.3 Global Endocrine Therapy Drugs for Breast Cancer Market by Application
1.3.1 Global Endocrine Therapy Drugs for Breast Cancer Market Size and Market Share Comparison by Applications (2014-2024)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Drug Center
1.3.5 Other
1.4 Global Endocrine Therapy Drugs for Breast Cancer Market by Regions
1.4.1 Global Endocrine Therapy Drugs for Breast Cancer Market Size (Million USD) Comparison by Regions (2014-2024)
1.4.1 North America (USA, Canada and Mexico) Endocrine Therapy Drugs for Breast Cancer Status and Prospect (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Endocrine Therapy Drugs for Breast Cancer Status and Prospect (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Endocrine Therapy Drugs for Breast Cancer Status and Prospect (2014-2024)
1.4.4 South America (Brazil, Argentina, Colombia) Endocrine Therapy Drugs for Breast Cancer Status and Prospect (2014-2024)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Endocrine Therapy Drugs for Breast Cancer Status and Prospect (2014-2024)
1.5 Global Market Size of Endocrine Therapy Drugs for Breast Cancer (2014-2024)
2 Manufacturers Profiles
2.1 Teva
2.1.1 Business Overview
2.1.2 Endocrine Therapy Drugs for Breast Cancer Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Teva Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.2 Amneal Pharms
2.2.1 Business Overview
2.2.2 Endocrine Therapy Drugs for Breast Cancer Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Amneal Pharms Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.3 AstraZeneca
2.3.1 Business Overview
2.3.2 Endocrine Therapy Drugs for Breast Cancer Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 AstraZeneca Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.4 Novartis
2.4.1 Business Overview
2.4.2 Endocrine Therapy Drugs for Breast Cancer Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Novartis Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.5 Intas Pharmaceuticals
2.5.1 Business Overview
2.5.2 Endocrine Therapy Drugs for Breast Cancer Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Intas Pharmaceuticals Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.6 Chemo
2.6.1 Business Overview
2.6.2 Endocrine Therapy Drugs for Breast Cancer Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Chemo Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.7 Accure Labs
2.7.1 Business Overview
2.7.2 Endocrine Therapy Drugs for Breast Cancer Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Accure Labs Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.8 Natco
2.8.1 Business Overview
2.8.2 Endocrine Therapy Drugs for Breast Cancer Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Natco Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.9 Zydus Pharmaceuticals
2.9.1 Business Overview
2.9.2 Endocrine Therapy Drugs for Breast Cancer Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Zydus Pharmaceuticals Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.10 Sanofi
2.10.1 Business Overview
2.10.2 Endocrine Therapy Drugs for Breast Cancer Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Sanofi Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.11 Pfizer
2.11.1 Business Overview
2.11.2 Endocrine Therapy Drugs for Breast Cancer Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Pfizer Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.12 Mylan 
2.12.1 Business Overview
2.12.2 Endocrine Therapy Drugs for Breast Cancer Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Mylan  Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.13 Wockhardt
2.13.1 Business Overview
2.13.2 Endocrine Therapy Drugs for Breast Cancer Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Wockhardt Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.14 Cipla
2.14.1 Business Overview
2.14.2 Endocrine Therapy Drugs for Breast Cancer Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Cipla Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.15 Actiza Pharmaceutical
2.15.1 Business Overview
2.15.2 Endocrine Therapy Drugs for Breast Cancer Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Actiza Pharmaceutical Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.16 Hikma Pharmaceuticals
2.16.1 Business Overview
2.16.2 Endocrine Therapy Drugs for Breast Cancer Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Hikma Pharmaceuticals Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.17 Shanghai Forward Technology
2.17.1 Business Overview
2.17.2 Endocrine Therapy Drugs for Breast Cancer Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Shanghai Forward Technology Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.18 Bayer
2.18.1 Business Overview
2.18.2 Endocrine Therapy Drugs for Breast Cancer Type and Applications
2.18.2.1 Product A
2.18.2.2 Product B
2.18.3 Bayer Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.19 Liaoning Kangtai Pharmaceutical
2.19.1 Business Overview
2.19.2 Endocrine Therapy Drugs for Breast Cancer Type and Applications
2.19.2.1 Product A
2.19.2.2 Product B
2.19.3 Liaoning Kangtai Pharmaceutical Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.20 Fu ‘an Pharmaceutical Group
2.20.1 Business Overview
2.20.2 Endocrine Therapy Drugs for Breast Cancer Type and Applications
2.20.2.1 Product A
2.20.2.2 Product B
2.20.3 Fu ‘an Pharmaceutical Group Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.21 Apotex
2.21.1 Business Overview
2.2.2 Endocrine Therapy Drugs for Breast Cancer Type and Applications
2.21.2.1 Product A
2.21.2.2 Product B
2.21.3 Apotex Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.22 Taro
2.22.1 Business Overview
2.22.2 Endocrine Therapy Drugs for Breast Cancer Type and Applications
2.22.2.1 Product A
2.22.2.2 Product B
2.22.3 Taro Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.23 Sun Phamaceutical
2.23.1 Business Overview
2.23.2 Endocrine Therapy Drugs for Breast Cancer Type and Applications
2.23.2.1 Product A
2.23.2.2 Product B
2.23.3 Sun Phamaceutical Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.24 Intas Pharmaceuticals
2.24.1 Business Overview
2.24.2 Endocrine Therapy Drugs for Breast Cancer Type and Applications
2.24.2.1 Product A
2.24.2.2 Product B
2.24.3 Intas Pharmaceuticals Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.25 Chemo
2.25.1 Business Overview
2.25.2 Endocrine Therapy Drugs for Breast Cancer Type and Applications
2.25.2.1 Product A
2.25.2.2 Product B
2.25.3 Chemo Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.26 Accure Labs
2.26.1 Business Overview
2.26.2 Endocrine Therapy Drugs for Breast Cancer Type and Applications
2.26.2.1 Product A
2.26.2.2 Product B
2.26.3 Accure Labs Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
2.27 Sun Pharmaceutical
2.27.1 Business Overview
2.27.2 Endocrine Therapy Drugs for Breast Cancer Type and Applications
2.27.2.1 Product A
2.27.2.2 Product B
2.27.3 Sun Pharmaceutical Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
3 Global Endocrine Therapy Drugs for Breast Cancer Market Competition, by Players
3.1 Global Endocrine Therapy Drugs for Breast Cancer Revenue and Share by Players (2014-2019)
3.2 Market Concentration Rate
3.2.1 Top 5 Endocrine Therapy Drugs for Breast Cancer Players Market Share
3.2.2 Top 10 Endocrine Therapy Drugs for Breast Cancer Players Market Share
3.3 Market Competition Trend
4 Global Endocrine Therapy Drugs for Breast Cancer Market Size by Regions
4.1 Global Endocrine Therapy Drugs for Breast Cancer Revenue and Market Share by Regions
4.2 North America Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
4.3 Europe Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
4.4 Asia-Pacific Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
4.5 South America Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
4.6 Middle East and Africa Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
5 North America Endocrine Therapy Drugs for Breast Cancer Revenue by Countries
5.1 North America Endocrine Therapy Drugs for Breast Cancer Revenue by Countries (2014-2019)
5.2 USA Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
5.3 Canada Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
5.4 Mexico Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
6 Europe Endocrine Therapy Drugs for Breast Cancer Revenue by Countries
6.1 Europe Endocrine Therapy Drugs for Breast Cancer Revenue by Countries (2014-2019)
6.2 Germany Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
6.3 UK Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
6.4 France Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
6.5 Russia Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
6.6 Italy Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
7 Asia-Pacific Endocrine Therapy Drugs for Breast Cancer Revenue by Countries
7.1 Asia-Pacific Endocrine Therapy Drugs for Breast Cancer Revenue by Countries (2014-2019)
7.2 China Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
7.3 Japan Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
7.4 Korea Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
7.5 India Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
7.6 Southeast Asia Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
8 South America Endocrine Therapy Drugs for Breast Cancer Revenue by Countries
8.1 South America Endocrine Therapy Drugs for Breast Cancer Revenue by Countries (2014-2019)
8.2 Brazil Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
8.3 Argentina Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
8.4 Colombia Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
9 Middle East and Africa Revenue Endocrine Therapy Drugs for Breast Cancer by Countries
9.1 Middle East and Africa Endocrine Therapy Drugs for Breast Cancer Revenue by Countries (2014-2019)
9.2 Saudi Arabia Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
9.3 UAE Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
9.4 Egypt Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
9.5 Nigeria Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
9.6 South Africa Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
10 Global Endocrine Therapy Drugs for Breast Cancer Market Segment by Type
10.1 Global Endocrine Therapy Drugs for Breast Cancer Revenue and Market Share by Type (2014-2019)
10.2 Global Endocrine Therapy Drugs for Breast Cancer Market Forecast by Type (2019-2024)
10.3 Tamoxifen Revenue Growth Rate (2014-2024)
10.4 Anastrozole Revenue Growth Rate (2014-2024)
10.5 Exemestane Revenue Growth Rate (2014-2024)
10.6 Letrozole Revenue Growth Rate (2014-2024)
10.7 Goserelin Revenue Growth Rate (2014-2024)
10.8 Fulvestrant Revenue Growth Rate (2014-2024)
11 Global Endocrine Therapy Drugs for Breast Cancer Market Segment by Application
11.1 Global Endocrine Therapy Drugs for Breast Cancer Revenue Market Share by Application (2014-2019)
11.2 Endocrine Therapy Drugs for Breast Cancer Market Forecast by Application (2019-2024)
11.3 Hospital Revenue Growth (2014-2019)
11.4 Clinic Revenue Growth (2014-2019)
11.5 Drug Center Revenue Growth (2014-2019)
11.6 Other Revenue Growth (2014-2019)
12 Global Endocrine Therapy Drugs for Breast Cancer Market Size Forecast (2019-2024)
12.1 Global Endocrine Therapy Drugs for Breast Cancer Market Size Forecast (2019-2024)
12.2 Global Endocrine Therapy Drugs for Breast Cancer Market Forecast by Regions (2019-2024)
12.3 North America Endocrine Therapy Drugs for Breast Cancer Revenue Market Forecast (2019-2024)
12.4 Europe Endocrine Therapy Drugs for Breast Cancer Revenue Market Forecast (2019-2024)
12.5 Asia-Pacific Endocrine Therapy Drugs for Breast Cancer Revenue Market Forecast (2019-2024)
12.6 South America Endocrine Therapy Drugs for Breast Cancer Revenue Market Forecast (2019-2024)
12.7 Middle East and Africa Endocrine Therapy Drugs for Breast Cancer Revenue Market Forecast (2019-2024)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source

List of Tables and Figures

Figure Endocrine Therapy Drugs for Breast Cancer Picture
Table Product Specifications of Endocrine Therapy Drugs for Breast Cancer
Table Global Endocrine Therapy Drugs for Breast Cancer and Revenue (Million USD) Market Split by Product Type
Figure Global Endocrine Therapy Drugs for Breast Cancer Revenue Market Share by Types in 2018
Figure Tamoxifen Picture
Figure Anastrozole Picture
Figure Exemestane Picture
Figure Letrozole Picture
Figure Goserelin Picture
Figure Fulvestrant Picture
Table Global Endocrine Therapy Drugs for Breast Cancer Revenue (Million USD) by Application (2014-2024)
Figure Endocrine Therapy Drugs for Breast Cancer Revenue Market Share by Applications in 2018
Figure Hospital Picture
Figure Clinic Picture
Figure Drug Center Picture
Figure Other Picture
Table Global Market Endocrine Therapy Drugs for Breast Cancer Revenue (Million USD) Comparison by Regions 2014-2024
Figure North America Endocrine Therapy Drugs for Breast Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Figure Europe Endocrine Therapy Drugs for Breast Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Figure Asia-Pacific Endocrine Therapy Drugs for Breast Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Figure South America Endocrine Therapy Drugs for Breast Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Figure Middle East and Africa Endocrine Therapy Drugs for Breast Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Figure Global Endocrine Therapy Drugs for Breast Cancer Revenue (Million USD) and Growth Rate (2014-2024)
Table Teva Basic Information, Manufacturing Base and Competitors
Table Teva Endocrine Therapy Drugs for Breast Cancer Type and Applications
Table Teva Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Amneal Pharms Basic Information, Manufacturing Base and Competitors
Table Amneal Pharms Endocrine Therapy Drugs for Breast Cancer Type and Applications
Table Amneal Pharms Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table AstraZeneca Basic Information, Manufacturing Base and Competitors
Table AstraZeneca Endocrine Therapy Drugs for Breast Cancer Type and Applications
Table AstraZeneca Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Endocrine Therapy Drugs for Breast Cancer Type and Applications
Table Novartis Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Intas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Intas Pharmaceuticals Endocrine Therapy Drugs for Breast Cancer Type and Applications
Table Intas Pharmaceuticals Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Chemo Basic Information, Manufacturing Base and Competitors
Table Chemo Endocrine Therapy Drugs for Breast Cancer Type and Applications
Table Chemo Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Accure Labs Basic Information, Manufacturing Base and Competitors
Table Accure Labs Endocrine Therapy Drugs for Breast Cancer Type and Applications
Table Accure Labs Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Natco Basic Information, Manufacturing Base and Competitors
Table Natco Endocrine Therapy Drugs for Breast Cancer Type and Applications
Table Natco Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Zydus Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Zydus Pharmaceuticals Endocrine Therapy Drugs for Breast Cancer Type and Applications
Table Zydus Pharmaceuticals Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Sanofi Basic Information, Manufacturing Base and Competitors
Table Sanofi Endocrine Therapy Drugs for Breast Cancer Type and Applications
Table Sanofi Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Endocrine Therapy Drugs for Breast Cancer Type and Applications
Table Pfizer Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Mylan  Basic Information, Manufacturing Base and Competitors
Table Mylan  Endocrine Therapy Drugs for Breast Cancer Type and Applications
Table Mylan  Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Wockhardt Basic Information, Manufacturing Base and Competitors
Table Wockhardt Endocrine Therapy Drugs for Breast Cancer Type and Applications
Table Wockhardt Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Cipla Basic Information, Manufacturing Base and Competitors
Table Cipla Endocrine Therapy Drugs for Breast Cancer Type and Applications
Table Cipla Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Actiza Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Actiza Pharmaceutical Endocrine Therapy Drugs for Breast Cancer Type and Applications
Table Actiza Pharmaceutical Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Hikma Pharmaceuticals Endocrine Therapy Drugs for Breast Cancer Type and Applications
Table Hikma Pharmaceuticals Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Shanghai Forward Technology Basic Information, Manufacturing Base and Competitors
Table Shanghai Forward Technology Endocrine Therapy Drugs for Breast Cancer Type and Applications
Table Shanghai Forward Technology Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Endocrine Therapy Drugs for Breast Cancer Type and Applications
Table Bayer Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Liaoning Kangtai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Liaoning Kangtai Pharmaceutical Endocrine Therapy Drugs for Breast Cancer Type and Applications
Table Liaoning Kangtai Pharmaceutical Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Fu 'an Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table Fu 'an Pharmaceutical Group Endocrine Therapy Drugs for Breast Cancer Type and Applications
Table Fu 'an Pharmaceutical Group Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Apotex Basic Information, Manufacturing Base and Competitors
Table Apotex Endocrine Therapy Drugs for Breast Cancer Type and Applications
Table Apotex Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Taro Basic Information, Manufacturing Base and Competitors
Table Taro Endocrine Therapy Drugs for Breast Cancer Type and Applications
Table Taro Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Sun Phamaceutical Basic Information, Manufacturing Base and Competitors
Table Sun Phamaceutical Endocrine Therapy Drugs for Breast Cancer Type and Applications
Table Sun Phamaceutical Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Intas Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Intas Pharmaceuticals Endocrine Therapy Drugs for Breast Cancer Type and Applications
Table Intas Pharmaceuticals Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Chemo Basic Information, Manufacturing Base and Competitors
Table Chemo Endocrine Therapy Drugs for Breast Cancer Type and Applications
Table Chemo Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Accure Labs Basic Information, Manufacturing Base and Competitors
Table Accure Labs Endocrine Therapy Drugs for Breast Cancer Type and Applications
Table Accure Labs Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Sun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Sun Pharmaceutical Endocrine Therapy Drugs for Breast Cancer Type and Applications
Table Sun Pharmaceutical Endocrine Therapy Drugs for Breast Cancer Revenue, Gross Margin and Market Share (2017-2018)
Table Global Endocrine Therapy Drugs for Breast Cancer Revenue (Million USD) by Players (2014-2019)
Table Global Endocrine Therapy Drugs for Breast Cancer Revenue Share by Players (2014-2019)
Figure Global Endocrine Therapy Drugs for Breast Cancer Revenue Share by Players in 2017
Figure Global Endocrine Therapy Drugs for Breast Cancer Revenue Share by Players in 2018
Figure Global Top 5 Players Endocrine Therapy Drugs for Breast Cancer Revenue Market Share in 2018
Figure Global Top 10 Players Endocrine Therapy Drugs for Breast Cancer Revenue Market Share in 2018
Figure Global Endocrine Therapy Drugs for Breast Cancer Revenue (Million USD) and Growth Rate (%) (2014-2019)
Table Global Endocrine Therapy Drugs for Breast Cancer Revenue (Million USD) by Regions (2014-2019)
Table Global Endocrine Therapy Drugs for Breast Cancer Revenue Market Share by Regions (2014-2019)
Figure Global Endocrine Therapy Drugs for Breast Cancer Revenue Market Share by Regions (2014-2019)
Figure Global Endocrine Therapy Drugs for Breast Cancer Revenue Market Share by Regions in 2018
Figure North America Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Europe Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Asia-Pacific Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure South America Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Middle East and Africa Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Table North America Endocrine Therapy Drugs for Breast Cancer Revenue by Countries (2014-2019)
Table North America Endocrine Therapy Drugs for Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure North America Endocrine Therapy Drugs for Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure North America Endocrine Therapy Drugs for Breast Cancer Revenue Market Share by Countries in 2018
Figure USA Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Canada Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Mexico Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Table Europe Endocrine Therapy Drugs for Breast Cancer Revenue (Million USD) by Countries (2014-2019)
Figure Europe Endocrine Therapy Drugs for Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure Europe Endocrine Therapy Drugs for Breast Cancer Revenue Market Share by Countries in 2018
Figure Germany Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure UK Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure France Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Russia Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Italy Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Endocrine Therapy Drugs for Breast Cancer Revenue (Million USD) by Countries (2014-2019)
Figure Asia-Pacific Endocrine Therapy Drugs for Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure Asia-Pacific Endocrine Therapy Drugs for Breast Cancer Revenue Market Share by Countries in 2018
Figure China Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Japan Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Korea Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure India Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Southeast Asia Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Table South America Endocrine Therapy Drugs for Breast Cancer Revenue by Countries (2014-2019)
Table South America Endocrine Therapy Drugs for Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure South America Endocrine Therapy Drugs for Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure South America Endocrine Therapy Drugs for Breast Cancer Revenue Market Share by Countries in 2018
Figure Brazil Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Argentina Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Colombia Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Endocrine Therapy Drugs for Breast Cancer Revenue (Million USD) by Countries (2014-2019)
Table Middle East and Africa Endocrine Therapy Drugs for Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Endocrine Therapy Drugs for Breast Cancer Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Endocrine Therapy Drugs for Breast Cancer Revenue Market Share by Countries in 2018
Figure Saudi Arabia Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure UAE Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Egypt Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure Nigeria Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Figure South Africa Endocrine Therapy Drugs for Breast Cancer Revenue and Growth Rate (2014-2019)
Table Global Endocrine Therapy Drugs for Breast Cancer Revenue (Million USD) by Type (2014-2019)
Table Global Endocrine Therapy Drugs for Breast Cancer Revenue Share by Type (2014-2019)
Figure Global Endocrine Therapy Drugs for Breast Cancer Revenue Share by Type (2014-2019)
Figure Global Endocrine Therapy Drugs for Breast Cancer Revenue Share by Type in 2018
Table Global Endocrine Therapy Drugs for Breast Cancer Revenue Forecast by Type (2019-2024)
Figure Global Endocrine Therapy Drugs for Breast Cancer Market Share Forecast by Type (2019-2024)
Figure Global Tamoxifen Revenue Growth Rate (2014-2019)
Figure Global Anastrozole Revenue Growth Rate (2014-2019)
Figure Global Exemestane Revenue Growth Rate (2014-2019)
Figure Global Letrozole Revenue Growth Rate (2014-2019)
Figure Global Goserelin Revenue Growth Rate (2014-2019)
Figure Global Fulvestrant Revenue Growth Rate (2014-2019)
Table Global Endocrine Therapy Drugs for Breast Cancer Revenue by Application (2014-2019)
Table Global Endocrine Therapy Drugs for Breast Cancer Revenue Share by Application (2014-2019)
Figure Global Endocrine Therapy Drugs for Breast Cancer Revenue Share by Application (2014-2019)
Figure Global Endocrine Therapy Drugs for Breast Cancer Revenue Share by Application in 2018
Table Global Endocrine Therapy Drugs for Breast Cancer Revenue Forecast by Application (2019-2024)
Figure Global Endocrine Therapy Drugs for Breast Cancer Market Share Forecast by Application (2019-2024)
Figure Global Hospital Revenue Growth Rate (2014-2019)
Figure Global Clinic Revenue Growth Rate (2014-2019)
Figure Global Drug Center Revenue Growth Rate (2014-2019)
Figure Global Other Revenue Growth Rate (2014-2019)
Figure Global Endocrine Therapy Drugs for Breast Cancer Revenue (Million USD) and Growth Rate Forecast (2019-2024)
Table Global Endocrine Therapy Drugs for Breast Cancer Revenue (Million USD) Forecast by Regions (2019-2024)
Figure Global Endocrine Therapy Drugs for Breast Cancer Revenue Market Share Forecast by Regions (2019-2024)
Figure North America Endocrine Therapy Drugs for Breast Cancer Revenue Market Forecast (2019-2024)
Figure Europe Endocrine Therapy Drugs for Breast Cancer Revenue Market Forecast (2019-2024)
Figure Asia-Pacific Endocrine Therapy Drugs for Breast Cancer Revenue Market Forecast (2019-2024)
Figure South America Endocrine Therapy Drugs for Breast Cancer Revenue Market Forecast (2019-2024)
Figure Middle East and Africa Endocrine Therapy Drugs for Breast Cancer Revenue Market Forecast (2019-2024)

---